Inovio Pharmaceuticals Analyst Ratings
Keefe, Bruyette & Woods Maintains Outperform on Baldwin Insurance, Lowers Price Target to $49
Getty Realty Analyst Ratings
Top 2 Health Care Stocks That Are Ticking Portfolio Bombs
(AMC) - Analyzing AMC Enter Hldgs's Short Interest
Blue Bird Option Alert: Jan 17 $45 Calls Sweep (5) Near the Ask: 1116 @ $0.4 Vs 2152 OI; Earnings 2/5 After Close [Est] Ref=$42.025
WisdomTree AUM Dipped 2.9% in December Amid Net Outflows
Here Are the Major Earnings After the Close Today
Shares of Airline Stocks Are Trading Higher in Sympathy With Delta, Which Rose After Reporting Strong Q4 Financial Results.
Kinetik Holdings Analyst Ratings
Citigroup Sees Restaurant Sector Facing a Challenging 2025
Looking Into Selective Insurance Gr's Recent Short Interest
KB Home, Lennar Upgraded at RBC Capital on Valuation, Balanced Risk/reward
Disney-Fox-Warner Trio to Disband Venu Sports in Wake of Legal Settlement With Fubo
Quanterix Shares Are Trading Lower After the Company Announced It Has Agreed to Acquire Akoya Biosciences in an All-stock Transaction.
Take-Two, Xometry: JPMorgan's Bets On Gaming, Manufacturing In 2025
BMO Capital Maintains Outperform on Intellia Therapeutics, Lowers Price Target to $50
Intellia Therapeutics Analyst Ratings
Watching TransMedics Shares, Scorpion Capital Publishes Report On Co. With $0 PT
Pacira Biosciences Shares Are Trading Higher After the Company Reported a Preliminary Year-over-year Increase in FY25 Revenue.